Hama Jakob, Smith Matthew, Erazo Geovanna
Internal Medicine, New York City Health and Hospitals Queens Hospital Center, 82-68 164th St, Queens, NY 11432, USA.
Interventional Radiology, New York City Health and Hospitals Queens Hospital Center, 82-68 164th St, Queens, NY 11432, USA.
Radiol Case Rep. 2024 Feb 22;19(5):1832-1835. doi: 10.1016/j.radcr.2024.01.066. eCollection 2024 May.
Port-A-Cath (port), a single-lumen, tunneled catheter, is routinely placed into the superior vena cava (SVC) for cancer patients undergoing chemotherapy. We present a case of a port placement in which variant anatomy was discovered during the fluoroscopy-guided procedure and confirmed by venogram of a persistent left-sided SVC (PLSVC). Upon further investigation into the patient's previous computed tomography (CT) scans, the diagnosis was further confirmed. Patients with PLSVC are typically asymptomatic; however, some are associated with increased congenital heart defects (CHD), which increase the risk for complications during invasive procedures. Diagnosing PLSVCs and knowing the clinical implications/complications can improve patient care; by not removing catheters unnecessarily and being prepared to treat/minimize complications.
植入式静脉输液港（输液港）是一种单腔、经隧道的导管，通常用于为接受化疗的癌症患者置入上腔静脉（SVC）。我们报告一例输液港置入病例，在透视引导操作过程中发现解剖变异，并经持续性左侧上腔静脉（PLSVC）静脉造影证实。对患者之前的计算机断层扫描（CT）进行进一步检查后，诊断得到进一步证实。PLSVC患者通常无症状；然而，一些患者伴有先天性心脏病（CHD）增加，这会增加侵入性操作期间并发症的风险。诊断PLSVC并了解其临床意义/并发症可改善患者护理；避免不必要地拔除导管，并做好治疗/将并发症降至最低的准备。
